Latest Regulatory Milestones News

Clarity Pharmaceuticals will present compelling data at EANM 2026 demonstrating its 64Cu-SAR-bisPSMA imaging agent’s superior detection of prostate cancer recurrence and promising therapeutic results from 67Cu-SAR-bisPSMA in advanced disease.

Audalia Resources (ASX: ACP) is seeking to raise $450,000 through a placement of 15 million shares at 3 cents each, aiming to fund the Medcalf project’s progression and shore up working capital.

Po Valley Energy has lodged a crucial Environmental Impact Assessment for a four-well gas drilling program at its Selva Malvezzi concession in Northern Italy, aiming to boost production and support regional energy needs.

Novatti has cashed in $1.2 million by selling part of its AUDC shares at $0.80 each, marking its first divestment since incubating the stablecoin issuer in 2022, yet keeps a substantial holding to benefit from future growth.

Echo IQ has locked in a binding Heads of Agreement with Pro Medicus for a strategic A$20 million investment and a US commercial partnership to accelerate adoption of its AI-powered cardiac diagnostic platform.

The a2 Milk Company has announced a $300 million fully franked special dividend following regulatory clearance in China to rebrand infant formula products under its a2 label.

American West Metals is finalising its Pre-Feasibility Study for the Storm Copper Project in Nunavut, advancing permitting and exploration along a 110km copper belt, backed by secured development funding.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.

Elementos Limited has secured a key regulatory milestone as the Regional Government of Andalucía grants its Oropesa Tin Project Overriding Public Interest status, easing the path for critical water licensing and advancing permitting certainty.

Sky Metals has reported new shallow, wide, high-grade tin-tungsten-silver drill intercepts at its Tallebung Project, expanding the deposit ahead of an imminent Mineral Resource Estimate and Pre-Feasibility Study.

The a2 Milk Company has clinched final Chinese regulatory approval to rebrand infant formula products under its flagship a2™ label, completing a pivotal acquisition step. The company plans to launch these products later in 2026 and is poised to declare a $300 million special dividend.